| 4.99 Data as of May 17 |  +0.04 / +0.81%Today’s Change | 4.13 Today|||52-Week Range 7.01 | -1.19% Year-to-Date |
| Previous close | 4.95 |
| Today’s open | 4.87 |
| Day’s range | 4.87 - 5.00 |
| Volume | 18,633 |
| Average volume (3 months) | 27,562 |
| Market cap | $65.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +25.71% |
| Earnings growth (this year) | -86.54% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -28.75% |
| P/E ratio | NM |
| Price/Sales | 8.11 |
| Price/Book | 4.37 |
| Today’s change | Today’s % change | |
|---|---|---|
| PSDVpSivida Corp | +0.04 | +1.43% |
| DRIOLabStyle Innovations... | +0.10 | +3.45% |
| CYTRCytRx Corp | -0.02 | -0.81% |
| CLSNCelsion Corp | +0.07 | +7.44% |
| Next reporting date | May 29, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $6.7M |
| Annual profit (last year) | -$2.8M |
| Net profit margin | -41.15% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Scott R. Pancoast, MBA |
Chief Financial Officer, Secretary & Senior VP Gary J. G. Atkinson, CPA |
Corporate headquarters San Diego, California |
.
